MUC16 and ovarian carcinoma: Developing accurately weighted marker scores for more than two markers (more than one additionally to CA125) will require larger numbers of ovarian cancer cases than in our present study and could be achieved by combining serum samples and data of ovarian cancer cases and matched control subjects from additional large-scale population cohorts worldwide.